No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Moderna Spikes as Oracle's Larry Ellison Touts AI-driven MRNA Vaccines
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery With AI and Strategic Collaborations for Strong Growth
Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028
Is Recursion Pharmaceuticals Stock a Buy?
Recursion Pharmaceuticals (RXRX) Rises Yet Lags Behind Market: Some Facts Worth Knowing